618 results on '"Kampman, Kyle"'
Search Results
2. Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects in brain regions associated with addiction
3. Disorders Due to Substance Use: Opioids and Opioid Addiction
4. Not in my treatment center: Leadership's perception of barriers to MOUD adoption
5. Gabapentin Enacarbil Extended‐Release for Alcohol Use Disorder: A Randomized, Double‐Blind, Placebo‐Controlled, Multisite Trial Assessing Efficacy and Safety
6. Deep Brain Stimulation Compared With Contingency Management for the Treatment of Cocaine Use Disorders: A Threshold and Cost-Effectiveness Analysis
7. Clinical Trials for Stimulant Use Disorders: Addressing Heterogeneities That May Undermine Treatment Outcomes
8. Analysis of genetic and clinical factors associated with buprenorphine response
9. Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder
10. It's not just the money: The role of treatment ideology in publicly funded substance use disorder treatment
11. The relationship between insomnia and the intensity of drinking in treatment-seeking individuals with alcohol dependence
12. Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users
13. Measures of outcome for stimulant trials: ACTTION recommendations and research agenda
14. Craving and opioid use disorder: A scoping review
15. Responding to the opioid and overdose crisis with innovative services: The recovery community center office-based opioid treatment (RCC-OBOT) model
16. Vaccine for cocaine dependence: A randomized double-blind placebo-controlled efficacy trial
17. Buprenorphine implants for opioid dependence
18. T79 - Engagement in OUD Treatment 6 Months After Community-Based Intervention
19. S67 - Transition to Antagonist Treatment in the Age of Fentanyl
20. Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African–Americans with opioid use disorder
21. Unseen scars: Cocaine patients with prior trauma evidence heightened resting state functional connectivity (RSFC) between the amygdala and limbic-striatal regions
22. Adapting psychotherapy in collaborative care for treating opioid use disorder and co-occurring psychiatric conditions in primary care.
23. Comparative effectiveness of urine drug screening strategies alongside opioid agonist treatment in British Columbia, Canada: a population-based observational study protocol
24. Clinical Trials for Stimulant Use Disorders: Addressing Heterogeneities That May Undermine Treatment Outcomes
25. General introduction: Issues and perspective on medication assisted treatment.
26. Executive Summary of the Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder
27. Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment
28. Depressive Symptomatology Is Associated With Smaller Reductions in Drug Cue Reactivity During Extended-Release Naltrexone Treatment of Opioid Use Disorder
29. Measures of outcome for stimulant trials: ACTTION recommendations and research agenda
30. Insomnia in alcohol dependent subjects is associated with greater psychosocial problem severity
31. Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder
32. A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence
33. A randomized, double‐blind, placebo‐controlled, pharmacogenetic study of ondansetron for treating alcohol use disorder
34. Vaccine for cocaine dependence: A randomized double-blind placebo-controlled efficacy trial
35. Emotional, physical and sexual abuse are associated with a heightened limbic response to cocaine cues
36. A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence
37. Case-control association study of WLS variants in opioid and cocaine addicted populations
38. Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects in brain regions associated with addiction.
39. A double-blind, placebo-controlled trial of modafinil for cocaine dependence
40. A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence
41. Modulation of resting brain cerebral blood flow by the GABA B agonist, baclofen: A longitudinal perfusion fMRI study
42. Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects on brain
43. Psychopharmacological Treatments for Substance Use Disorders
44. Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl.
45. Combined effects of alcohol and hepatitis C: A secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependence
46. Comparison of Treatments for Cocaine Use Disorder Among Adults
47. 68. CROSS-ANCESTRY META-ANALYSIS OF OPIOID USE DISORDER UNCOVERS NOVEL ASSOCIATED LOCI
48. American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use
49. The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study
50. Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.